All In MedTech

Device Trial Radar · NCT07842224

The Effect of Digitally Enabled District (DED 2.0) Ecosystem on the Completeness and Timeliness of Maternal and Neonatal Services in Primary Health Care

The Effect of Digitally Enabled District (DED 2.0) Ecosystem on the Completeness and Timeliness of Maternal and Neonatal Services in Primary Health Care: A Stepped-Wedge Cluster Randomised Trial in Garut Regency, Indonesia

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 10,800 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

10,800

Planned (sponsor's estimate)

Start

Oct 22, 2026

Primary completion

May 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Summit Institute for Development, IndonesiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Bill and Melinda Gates Foundation
First posted
Sep 25, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Health services research
FDA-regulated device
No
Who can join
Female only
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

DED 2.0 is a stepped-wedge cluster-randomized trial testing whether an integrated digital health ecosystem (KuApps, a service-monitoring dashboard, AI-assisted OCR for handwritten records, two-way WhatsApp-based health communication, and an automated worker-support tool) improves the completeness and timeliness of maternal and neonatal primary health care services, delivered through 45 Puskesmas in Garut Regency, West Java, Indonesia.

Conditions

  • Digital Health
  • Maternal Health Services
  • Prenatal Care
  • Intensive Care, Neonatal
  • Postnatal Care

Interventions

  • Digitally Enabled District (DED)Device

    The research adopts a stepped-wedge cluster-randomized design. Puskesmas are randomized sequentially to receive the intervention. Following a one-month baseline (retrospective data of Aug-Sept, taken in October), an additional set of 15 clusters begins the intervention at the start of each three-month step: step one covers randomisation and digital-readiness training for that wave, and the remainder of the step is given over to monitoring utilisation of the digital platform. Three successive steps of three months each follow this pattern until the full sample is covered, within a 9-month rollout-and-monitoring window.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Completeness of Antenatal Care (ANC) Services within the Gestational-Age WindowTime frame: From first ANC contact up to 40 weeks gestation, assessed up to 9 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Summit Institute for Development

    Mataram, West Nusa Tenggara, Indonesia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.